Student Name
Introduction
In the context of global transformations, healthcare systems represent a critical arena where economic, social, and political forces intersect, influencing equity, access, and efficiency worldwide. This essay draws on the documentary “Healthcare: America Vs the World” (assuming it refers to comparative analyses similar to those in documentaries like Michael Moore’s “Sicko,” as I am unable to verify the exact content of a documentary titled precisely as such without direct access; if this is inaccurate, please clarify). It briefly discusses Canada’s healthcare system, then analyses how the US system differs, emphasising why the US incurs the highest global healthcare costs. Supported by evidence from authoritative sources, the discussion highlights systemic differences amid globalisation’s push for universal health coverage. Key points include structural models, funding mechanisms, and cost drivers, evaluated from a global transformation perspective.
Canada’s Healthcare System
Canada’s healthcare system, often termed Medicare, operates as a publicly funded, universal model established under the Canada Health Act of 1984. It provides essential medical services to all citizens and permanent residents without direct charges at the point of care, funded primarily through taxation at federal and provincial levels (Government of Canada, 2023). Provinces administer the system, ensuring portability and comprehensiveness, though challenges persist, such as wait times for non-emergency procedures—typically 20-30 weeks for specialties like orthopaedics (Barua and Moir, 2022). This decentralised approach reflects global transformations towards equitable access, influenced by post-World War II welfare state models. However, it excludes certain services like dental care and prescription drugs outside hospitals, leading to supplementary private insurance for about 70% of Canadians (Marchildon, 2013). Arguably, this hybrid element introduces inefficiencies, yet the system’s emphasis on universality contrasts sharply with market-driven alternatives, promoting social cohesion in a diverse, immigrant-rich society.
Differences Between US and Canadian Healthcare Systems
The US healthcare system diverges fundamentally from Canada’s, embodying a predominantly private, market-oriented framework with fragmented public elements like Medicare (for seniors) and Medicaid (for low-income groups). Unlike Canada’s single-payer model, the US relies on employer-sponsored insurance, individual plans, and out-of-pocket payments, leaving approximately 8% of the population uninsured as of 2022 (Tolbert et al., 2023). This multiplicity results in higher administrative burdens; for instance, US hospitals dedicate 25% of spending to administration compared to Canada’s 12% (Himmelstein et al., 2014). Furthermore, the US lacks universal coverage, exacerbating inequalities—racial minorities and low-income groups face barriers, with 20% of Black Americans uninsured versus a national average of 8% (Artiga et al., 2020). In global transformation terms, these differences underscore neoliberal influences in the US, prioritising competition over equity, while Canada’s system aligns with social democratic principles, fostering broader access amid economic globalisation.
Why the US Healthcare System is the Most Expensive
The US healthcare system’s exorbitant costs—exceeding $4.3 trillion in 2021, or 18.3% of GDP—stem from several interrelated factors, making it the world’s most expensive (CMS, 2022). High pharmaceutical prices, driven by patent protections and minimal government negotiation, are a primary driver; for example, insulin costs $300 per vial in the US versus $30 in Canada (Mulcahy et al., 2018). Administrative inefficiencies, including billing complexities across insurers, inflate expenses by an estimated $265 billion annually (Himmelstein et al., 2021). Additionally, provider charges are elevated due to limited regulation; a hip replacement averages $40,000 in the US compared to $20,000 in Canada (International Federation of Health Plans, 2019). Evidence from the OECD indicates US per capita spending at $12,318 in 2022, double Canada’s $6,319, yet with inferior outcomes like lower life expectancy (78.8 years vs. 82.4 years) (OECD, 2023). These disparities, evaluated critically, reveal how profit motives in a privatised system, amid global market pressures, prioritise innovation (e.g., advanced technologies) but at the expense of affordability and efficiency—indeed, a limitation in applying market solutions to public goods.
Conclusion
In summary, Canada’s universal, publicly funded healthcare system contrasts with the US’s privatised, fragmented model, highlighting differences in access, administration, and equity. The US’s high costs arise from unregulated pricing, administrative waste, and market dynamics, supported by empirical evidence. From a global transformation viewpoint, this underscores the need for policy reforms towards hybrid models, balancing efficiency with universality to address inequalities in an interconnected world. Ultimately, while the US excels in innovation, its expense reveals systemic limitations, urging reconsideration amid ongoing globalisation.
References
- Artiga, S., Hill, L., Orgera, K. and Damico, A. (2020) Health Coverage by Race and Ethnicity, 2010-2019. Kaiser Family Foundation.
- Barua, B. and Moir, M. (2022) Waiting Your Turn: Wait Times for Health Care in Canada, 2022 Report. Fraser Institute. Available at: https://www.fraserinstitute.org/sites/default/files/waiting-your-turn-2022-report.pdf.
- Centers for Medicare & Medicaid Services (CMS). (2022) National Health Expenditure Data. Available at: https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/nationalhealthexpenddata/nationalhealthaccountshistorical.
- Government of Canada. (2023) Canada’s Health Care System. Available at: https://www.canada.ca/en/health-canada/services/canada-health-care-system.html.
- Himmelstein, D.U., Campbell, T. and Woolhandler, S. (2021) ‘Health Care Administrative Costs in the United States and Canada, 2017’, Annals of Internal Medicine, 172(2), pp. 134-142.
- Himmelstein, D.U., Woolhandler, S., Almberg, M. and Fauke, C. (2014) ‘A Comparison of Hospital Administrative Costs in Eight Nations: US Costs Exceed All Others by Far’, Health Affairs, 33(9), pp. 1586-1594.
- International Federation of Health Plans. (2019) 2019 Comparative Price Report. Available at: https://healthcostinstitute.org/images/pdfs/ifhp_2019_comparative_price_report_090720.pdf.
- Marchildon, G.P. (2013) Canada: Health System Review. Health Systems in Transition, 15(1). European Observatory on Health Systems and Policies.
- Mulcahy, A., Whaley, C., Tebeka, M.G., Schwam, D., Edenfield, N. and Becerra-Ornelas, A.U. (2018) International Prescription Drug Price Comparisons: Current Empirical Estimates and Comparisons with Previous Studies. RAND Corporation. Available at: https://www.rand.org/pubs/research_reports/RR2956.html.
- OECD. (2023) Health Spending (indicator). Available at: https://data.oecd.org/healthres/health-spending.htm.
- Tolbert, J., Drake, P. and Pollitz, K. (2023) Tracking Health Insurance Coverage in 2020-2021. Kaiser Family Foundation.
(Word count: 752)
